According to P&S intelligence, the U.S. scar treatment market was valued at $6.3 billion in terms of revenue in 2017 and it is estimated to register a CAGR of 10.4% during the forecast period (2018–2023). The market progress is backed by the increasing prevalence of skin problems, advancements in dermatological device technologies, growing number of road accidents, rise in the volume of surgeries, surging awareness about several scar treatments, and growing spending on personal care.